AbbVie’s $63 Billion Mistake

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 25, 2019 at 7:32 PM.

  1. #1 cafead, Jun 25, 2019 at 7:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via AbbVie (NYSE: ABBV) announced this morning its intention to acquire Irish drugmaker Allergan (NYSE: AGN) in a stock-and-cash deal for $63 billion (or $188.24 per share). More specifically, AbbVie is offering Allergan shareholders $120.30 in cash and 0.866 AbbVie shares per share of Allergan they currently own.

    article source
     
    Quote

Reply to Thread